KCT0001805招募中未知
Phase I study for evaluation of the safety of high dose hypofractionated radiotherapy in early stage glottic cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •A. Age: 20 years or older.
- •B. Histologically confirmed squamous cell carcinoma in vocal cords
- •C. Clinical stage T1-2N0M0
- •D. Performance status: ECOG 0-2, KPS 50-100
- •E. Decided to participate in this clinical trial voluntarily, and signed the written informed consent
排除标准
- •A. Prior neck radiotherapy
- •B. Palliative aim
- •C. Involved in posterior commissure
研究者
相似试验
撤回
1 期
Safety and tolerability of the Traditional Chinese Medicine Formulation GOPAC in patients with advanced malignancyAdvanced malignancy (palliative)Cancer - Other cancer typesACTRN12609000652279Sydney South West Area Health Service70
已完成
2 期
Anti aging efficacy of HIFU therapy using Anika deviceIRCT20190210042676N5Parnian Gostar Parto Sanj company30
进行中（未招募）
1 期
study to investigate the safety and clinical activity of APR-246 in combination with dabrafenib in patients with unresectable metastatic melanoma resistant to dabrafenib /trametinib combinatioEUCTR2017-002577-18-BEAPREA THERAPEUTICS AB50
招募中
Unknown
A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stageGastric cancerJPRN-UMIN000053317Iwate Prefectural Isawa Hospital22
已完成
不适用
A Pilot Study to Evaluate Safety and Efficacy of HLA-mismatched Granulocyte Transfusions in the Treatment of Patients with Solid Malignant Tumors Who Are Resistant to Standard Cancer Therapy or for Whom No Standard Cancer Therapy ExistsCTRI/2012/11/003116Munogenics Inc USA22